BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 63 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,408,385 | -14.7% | 16,732,000 | -13.8% | 1.23% | -18.0% |
| Q2 2023 | $19,245,611 | -21.7% | 19,413,000 | -19.1% | 1.50% | -19.6% |
| Q1 2023 | $24,566,321 | -23.7% | 23,984,000 | -20.9% | 1.87% | -6.7% |
| Q4 2022 | $32,180,694 | +14.5% | 30,334,000 | +6.9% | 2.00% | +27.0% |
| Q3 2022 | $28,116,000 | -3.6% | 28,381,000 | -4.7% | 1.58% | -10.8% |
| Q2 2022 | $29,160,000 | -1.2% | 29,791,000 | -1.2% | 1.77% | -52.5% |
| Q1 2022 | $29,510,000 | -6.1% | 30,138,000 | -1.8% | 3.72% | +74.0% |
| Q4 2021 | $31,428,000 | -8.6% | 30,692,000 | -9.2% | 2.14% | -18.7% |
| Q3 2021 | $34,381,000 | +20.6% | 33,796,000 | +23.9% | 2.63% | +1.2% |
| Q2 2021 | $28,508,000 | +1.6% | 27,278,000 | -1.0% | 2.60% | -20.6% |
| Q1 2021 | $28,071,000 | -3.7% | 27,562,000 | +2.2% | 3.27% | +7.6% |
| Q4 2020 | $29,149,000 | +8.7% | 26,959,000 | +6.6% | 3.04% | -4.0% |
| Q3 2020 | $26,805,000 | -2.1% | 25,291,000 | +14.0% | 3.17% | -19.2% |
| Q2 2020 | $27,393,000 | +25.0% | 22,185,000 | +6.6% | 3.92% | +19.7% |
| Q1 2020 | $21,912,000 | -1.8% | 20,815,000 | -0.5% | 3.28% | +13.1% |
| Q4 2019 | $22,305,000 | -8.8% | 20,916,000 | -15.2% | 2.90% | +3.6% |
| Q3 2019 | $24,447,000 | -9.7% | 24,674,000 | -4.8% | 2.80% | -9.0% |
| Q2 2019 | $27,077,000 | +2.0% | 25,929,000 | +0.2% | 3.07% | -10.0% |
| Q1 2019 | $26,548,000 | -1.0% | 25,885,000 | -3.8% | 3.41% | -13.0% |
| Q4 2018 | $26,819,000 | -0.1% | 26,902,000 | +7.1% | 3.92% | +20.6% |
| Q3 2018 | $26,845,000 | +61.9% | 25,130,000 | +53.5% | 3.25% | +62.5% |
| Q2 2018 | $16,578,000 | +8.1% | 16,370,000 | +0.4% | 2.00% | +22.0% |
| Q1 2018 | $15,340,000 | -5.0% | 16,298,000 | +0.9% | 1.64% | -10.8% |
| Q4 2017 | $16,139,000 | – | 16,159,000 | – | 1.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |